Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Jubilant Biosys strengthens its leadership team with two key appointments
Jubilant Biosys strengthens its leadership team with two key appointments
Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry
GSK names new Chief Executive
GSK names new Chief Executive
Emma Walmsley, currently head of GSK's Consumer Healthcare division, will succeed Andrew Witty
CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations
CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations
Bartlett will be based at the contract research organisation's Laval site in North America
XenoGesis aims to expand into US market
XenoGesis aims to expand into US market
Appoints Sabrina Mogle as a business development specialist to spearhead growth in the region
DS Biopharma appoints new Chief Operating Officer
DS Biopharma appoints new Chief Operating Officer
Dr Markus Weissbach moves to new role from Medical Director
ClinTec International expands US management team
ClinTec International expands US management team
Rick Farris appointed Executive Vice-President of North American Operations
Strategic appointment at Brenntag UK & Ireland
Strategic appointment at Brenntag UK & Ireland
Brenntag UK & Ireland announces the appointment of Tamara Durak to the position of Pharma & Cosmetics Business Manager
Helix BioPharma appoints new Director
Helix BioPharma appoints new Director
Dr Theordore J. Witek brings more than three decades of clinical development, medical affairs and commercial experience
Silence Therapeutics appoints Dmitry Samarsky as Chief Scientific Officer and Dr Andy Richards as Non-Executive Director
Silence Therapeutics appoints Dmitry Samarsky as Chief Scientific Officer and Dr Andy Richards as Non-Executive Director
Silence's technology harnesses the body’s natural mechanisms to create therapeutic effects within its cells
PureTech's Gelesis appoints chief operating officer and vice president of medical affairs
PureTech's Gelesis appoints chief operating officer and vice president of medical affairs
Former Boehringer Ingelheim vice president will lead commercialisation and operations efforts
Vaximm appoints Dr Matthias Schroff as Chief Executive Officer
Vaximm appoints Dr Matthias Schroff as Chief Executive Officer
Dr Schroff joins the Swiss/German biotechnology firm with more than 15 years of experience
Scientific Analysis Laboratories (SAL) welcomes Simon Cliff as Business Development Manager
Scientific Analysis Laboratories (SAL) welcomes Simon Cliff as Business Development Manager
Cliff has more than 20 years of experience of business development in the laboratory testing industry
Crown Bioscience expands leadership team
Crown Bioscience expands leadership team
Two people join the cardiovascular and metabolic disease portfolio at the US research services firm
TapImmune appoints Michael J. Loiacono as Chief Financial Officer
TapImmune appoints Michael J. Loiacono as Chief Financial Officer
Loiacono will also act as Corporate Secretary
TxCell appoints Biogen’s Dr Olivier Danos to its Scientific Advisory Board
TxCell appoints Biogen’s Dr Olivier Danos to its Scientific Advisory Board
TxCell's Scientific Advisory Board now includes four world-leading immunology experts
Trialbee hires senior executives from the pharma industry
Trialbee hires senior executives from the pharma industry
Swedish e-clinical solutions developer hires former H. Lundbeck and Bristol-Myers Squibb executives to Board
Previous
1
…
91
92
93
94
(current)
95
96
97
…
215
Next
Trending Articles
FUJIFILM Biotechnologies transitions leadership to drive next phase of operational excellence
FUJIFILM Biotechnologies today announced a planned leadership evolution as the Company enters its next phase of execution and sustainable growth
Clinilabs announces leadership expansion
Laura Shannon joins the organisation as Chief Executive Officer while Gary Zammit, the Company’s founder, assumes the role of Executive Chairperson
Piramal Pharma completes acquisition of controlling stake in Yapan Bio
Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering
Pace appoints Andy Fenny as President of Pace Life Sciences
Experienced life sciences executive brings more than 20 years of CDMO and pharmaceutical leadership to drive strategic growth
Clinilabs announces medical leadership appointments
Bob Dagher, M.D., named chief medical officer and Waqar Ahmed Siddiqui, M.D., named principal investigator
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all